Status:
COMPLETED
Bile Acids and Incretins in Pancreas Kidney Transplant Patients
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Pancreas-kidney Transplantation
Kidney Transplantation
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Pancreas Kidney Transplantation (PKT) is the prominent treatment for type 1 diabetic patients with chronic kidney disease and improves patients' outcome. However, in spite of an optimized systemic ins...
Eligibility Criteria
Inclusion
- Patients :
- BMI \<30 kg/m2
- Candidate for a first kidney transplant with a donor without the United Network for Organ Sharing (UNOS) criteria of extended donors and including living donors and pancreas-kidney donors (duodena-pancreas with ileal anastomosis and systemic drainage)
- Patients with conventional immunosuppression (maintenance with steroids, Tacrolimus and Mycophenolate Mofetil
- Willing and able to give informed consent
- Control subjects :
- Potential living kidney donor
Exclusion
- Subjects with a history of colectomy, gut resection or cholecystectomy
- For women : pregnancy
- Type 2 diabetes
- Type 1 diabetes
Key Trial Info
Start Date :
September 5 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02234349
Start Date
September 5 2013
End Date
March 23 2017
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Edourad Herriot - Pavillon P
Lyon, France, 69437